Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Dehydroepiandrosterone (Micronized) (75mg) + L-Methyl Folate (1mg) + Vitamin D3 (2000IU) Tablet
Therapeutic Category
Endocrinology, ENDOCRINOLOGY and Hormonal range, Gynecology and Fertility
Dosage Form
Tablet
Packaging Type
Alu Alu
Packaging
10*10
Price
₹1/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Ovaflip D3 Tablet containing Dehydroepiandrosterone, L-Methyl Folate, and Vitamin D3 is used for supporting female reproductive health and fertility. It helps in maintaining hormonal balance and improving overall reproductive function.
Dehydroepiandrosterone (DHEA) supports hormonal regulation, L-Methyl Folate aids in proper cell function and reproductive health, while Vitamin D3 contributes to hormonal balance and metabolic support. This combination helps in enhancing fertility outcomes and overall well-being.
The tablet is widely recommended in gynecology practice for fertility support and hormonal health, leading to steady demand and repeat usage in women’s health care.
With increasing awareness about fertility and reproductive wellness, this product offers strong business potential for retailers and distributors. Its growing demand, repeat consumption pattern, and expanding market acceptance make it a valuable product for consistent sales and growth in the gynecology segment.
Some individuals may experience mild acne, oily skin, hair changes, or gastrointestinal discomfort. Rarely, hormonal imbalance-related effects may occur and should be monitored under medical supervision.
Ovaflip D3 Tablet is indicated for women with hormonal imbalance, reduced ovarian reserve, or fertility concerns such as in cases of polycystic ovarian syndrome (PCOS) or assisted reproductive treatments. It helps regulate hormonal levels, support ovulation, improve egg quality, and enhance chances of conception.
This medicine should be used under medical supervision. Hormonal levels should be monitored during therapy. It is not recommended for use without proper evaluation, especially in patients with hormone-sensitive conditions.
Store in a cool, dry place below 25°C, protected from moisture and direct sunlight. Keep the tablets in their original packaging and out of reach of children.
Composition : Urofollitropin (75IU) Injection
Composition : Ashwgandha Ext 90 mg + Shatavari 90mg + Safed musli 90mg + Horny Goat Weed 80mg + Tribulus terestris 50 mg + Fenugreek 30 mg + Mucuna pruriens 40 mg + Shilajit. 30 mg
Composition : Co-enzyme Q10 60mg + DHA 10% 200mg + Panax Ginseng extract 90mg + Lycopene 10% 4mcg + Glutathione 50mg + Astaxanthin 8mg + L-Carnitine Tartrate 200mg + L-Arginine 250mg + Zince 17mg + Selenium 40mcg + Magnesium 100mg + Vitamin C 40mg + Vitamin A 1000 IU + Vitamin D3 400 IU + Vitamin B12 1mcg + Vitamin B1 1.40mg
Composition : Coenzyme Q10 100mg + DHA 10% 90mg + Melatonin 2mg + Chromium Picolinate 200mcg + N-acetyl L-cysteine 50mg + L-arginine 25mg + Zinc 15mg + Folic Acid 176.46mcg + Selenium 40mcg + Iodine 50mcg + Vitamin C 40mg + Vitamin A 1000 IU + Vitamin D3 400 IU + Vitamin B12 1mcg
Composition : Micronised Dehydroepiandrosterone 75mg + Melatonin 3mg + Ubidecarenone (Coezyme Q10) 100mg (DRUG)
Composition : Astaxanthin (16mg) + Reduced Coenzyme Q10 (200mg)
Composition : Astaxanthin 8mg, Coenyme Q10 10 mg, L-Carnitine L- Tartrate 500mg ,Vitamin k27 50 mcg, Magnesium sulphate 50 mg and Zinc sulphate 7.5 mg
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Ovaflip D3 Tablet, containing Dehydroepiandrosterone (DHEA) 75mg, L-Methyl Folate 1mg, and Vitamin D3 2000 IU, has strong demand in the gynecology, fertility support, and women’s wellness segment, making it a profitable product for medical distributors, wholesalers, and pharma franchise partners focusing on reproductive health portfolios.
Medical distributors and agencies can benefit from the increasing demand for supplements used in fertility support, hormonal balance, ovarian health, and reproductive wellness. Ovaflip D3 Tablet helps strengthen a comprehensive gynecology and women’s health product portfolio.
Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Ovaflip D3 Tablet with promotional support, monopoly rights, quality packaging, and competitive pricing for distributors and wholesalers.
Wholesalers and medical agencies benefit from attractive business margins, reliable product availability, professional support, and access to a trusted women’s fertility and wellness product range when partnering for Ovaflip D3 Tablet distribution.
Medical distributors, stockists, and wholesalers interested in Ovaflip D3 Tablet can contact Cafoli LifeCare Pvt Ltd to discuss franchise opportunities, bulk supply requirements, pricing, and distribution support.